David E. Lazar - 06 Feb 2025 SCHEDULE 13D Report for Cyclacel Pharmaceuticals, Inc. Common Stock, $0.001 par value (CYCC)

Filing Manager: David E. Lazar
Reporting Manager: Lazar David E.
Security: Cyclacel Pharmaceuticals, Inc. Common Stock, $0.001 par value
Symbol: CYCC
Shares outstanding: 246M shares
Disclosed Ownership: 39M shares
Ownership: 15.8%
Form type: SCHEDULE 13D
Filing time: 28 Feb 2025, 16:46:36 UTC
Date of event: 06 Feb 2025
Next filing: 04 Aug 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Lazar David E.	15.84%	39M	39M	0	/s/ David E. Lazar	David E. Lazar	0001932843